Drug points: Paroxetine and hepatotoxicity

BMJ

Volumn 314, Issue 7091, 1997, Pages 1387-

  Benbow, S J ^a   Gill, G ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CASE REPORT; CELL INFILTRATION; CHRONIC ACTIVE HEPATITIS; DEPRESSION; ECHOGRAPHY; EOSINOPHIL; FEMALE; HUMAN; LIVER BIOPSY; LIVER TOXICITY; PRIORITY JOURNAL;

AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; FEMALE; HEPATITIS, TOXIC; HUMANS; PAROXETINE;

EID: 85007664500     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.314.7091.1387a     Document Type: Article

References (3)

1. Castiella A, Arenas JI. Fluoxetine hepatotoxicity. Am J Gastroenterol 1994; 89: 458–459.
2. Mars F, Dumas de la Roque G, Goissen P. Hepatite aigue lors du traitement par la fluoxetine. Gastroenterol Clin Biol 1991; 15: 270–271.
3. Dunbar GC, Claghorn JL, Kiev A, Rickels K, Smith WT. A comparison of paroxetine and placebo in depressed patients. Acta Psychiatr Scand 1993; 87: 302–5